LBA Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$92K Hold
1,136
0.05% 152
2016
Q4
$81K Sell
1,136
-100
-8% -$7.86K 0.04% 159
2016
Q3
$107K Sell
1,236
-70
-5% -$6.1K 0.06% 150
2016
Q2
$113K Sell
1,306
-25
-2% -$2.02K 0.06% 143
2016
Q1
$100K Buy
1,331
+1,199
+908% +$90.3K 0.06% 151
2015
Q4
$10K Sell
132
-131
-50% -$9.86K 0.01% 293
2015
Q3
$18K Sell
263
-800
-75% -$58.9K 0.01% 232
2015
Q2
$79K Hold
1,063
0.05% 146
2015
Q1
$83K Buy
1,063
+47
+5% +$3.56K 0.05% 144
2014
Q4
$73K Sell
1,016
-55
-5% -$3.82K 0.05% 156
2014
Q3
$66K Buy
1,071
+186
+21% +$11.8K 0.05% 159
2014
Q2
$56K Buy
885
+85
+11% +$5.16K 0.05% 158
2014
Q1
$49K Hold
800
0.04% 161
2013
Q4
$46K Buy
+800
New +$45.4K 0.04% 160

Other funds holding MDT

LBA Wealth Management's MDT Position: Q1 2017 in Review

LBA Wealth Management held its Medtronic (MDT) position steady in Q1 2017 at 1,136 shares worth $92K. The position accounts for 0.05% of the portfolio, ranked #152.

LBA Wealth Management first reported a position in MDT in Q4 2013 and has held it in 14 quarters since. The position peaked at $113K in Q2 2016. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

  • LBA Wealth Management held 1,136 shares of Medtronic worth $92K as of Q1 2017.
  • LBA Wealth Management left its Medtronic share count unchanged in Q1 2017.
  • Medtronic made up 0.05% of LBA Wealth Management's portfolio in Q1 2017, its #152 holding.
  • LBA Wealth Management first reported a position in Medtronic in Q4 2013 and has held it in 14 quarters since.
  • LBA Wealth Management's Medtronic position peaked at $113K in Q2 2016.
  • 1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.